SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / ORD SHS
Total 13F shares
23,716,063
Share change
+2,589,369
Total reported value
$199,221,081
Put/Call ratio
1275%
Price per share
$8.40
Number of holders
79
Value change
+$22,003,411
Number of buys
51
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q4 2016

As of 31 Dec 2016, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,716,063 shares. The largest 10 holders included Senvest Management, LLC, BRANDES INVESTMENT PARTNERS, LP, NORTH TIDE CAPITAL, LLC, Camber Capital Management LLC, DALTON GREINER HARTMAN MAHER & CO, RENAISSANCE TECHNOLOGIES LLC, Migdal Insurance & Financial Holdings Ltd., HealthInvest Partners AB, MENORA MIVTACHIM HOLDINGS LTD., and PERRITT CAPITAL MANAGEMENT INC. This page lists 79 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.